Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Pulse Biosciences (PLSE) Shares Outstanding (2020 - 2025)

Pulse Biosciences has reported Shares Outstanding over the past 6 years, most recently at $67.7 million for Q3 2025.

  • Quarterly results put Shares Outstanding at $67.7 million for Q3 2025, up 10.11% from a year ago — trailing twelve months through Sep 2025 was $67.7 million (up 10.11% YoY), and the annual figure for FY2024 was $65.9 million, up 19.55%.
  • Shares Outstanding for Q3 2025 was $67.7 million at Pulse Biosciences, up from $67.3 million in the prior quarter.
  • Over the last five years, Shares Outstanding for PLSE hit a ceiling of $67.7 million in Q3 2025 and a floor of $26.4 million in Q1 2021.
  • Median Shares Outstanding over the past 5 years was $55.0 million (2023), compared with a mean of $48.7 million.
  • Biggest five-year swings in Shares Outstanding: crashed 87.88% in 2021 and later soared 1117.73% in 2022.
  • Pulse Biosciences' Shares Outstanding stood at $55.1 million in 2021, then crashed by 32.48% to $37.2 million in 2022, then skyrocketed by 48.1% to $55.1 million in 2023, then grew by 19.55% to $65.9 million in 2024, then grew by 2.75% to $67.7 million in 2025.
  • The last three reported values for Shares Outstanding were $67.7 million (Q3 2025), $67.3 million (Q2 2025), and $67.3 million (Q1 2025) per Business Quant data.